Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001654954-17-001992
Filing Date
2017-03-14
Accepted
2017-03-14 16:13:02
Documents
12
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT AMENDMENT NO. 1 cbmg10-k.htm 10-K/A 3830272
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cbmg_ex31.htm EX-31 18355
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cbmg_ex32.htm EX-32 9814
4 IMAGE cbmg10-k000.jpg GRAPHIC 28985
5 IMAGE cbmg10-k003.jpg GRAPHIC 29050
6 IMAGE cbmg10-k004.jpg GRAPHIC 16736
7 IMAGE cbmg10-k027.jpg GRAPHIC 19521
8 IMAGE cbmg10-k028.jpg GRAPHIC 9569
9 IMAGE cbmg10-k029.jpg GRAPHIC 14820
10 IMAGE cbmg10-k030.jpg GRAPHIC 14521
11 IMAGE cbmg10-k033.jpg GRAPHIC 10465
12 IMAGE cbmg10-k034.jpg GRAPHIC 14971
  Complete submission text file 0001654954-17-001992.txt   4079287
Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014 (408) 973-7884
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36498 | Film No.: 17688182
SIC: 2836 Biological Products, (No Diagnostic Substances)